Available at a Discount Over 50%: Should You Buy These 2 Cannabis Stocks?

Their weak cash position and operating losses make Aurora Cannabis and HEXO riskier bets.

| More on:

The slew of structural challenges, such as lower-than-expected demand, higher production, thriving black market sales, and pricing pressure, have put pressure on the cannabis sector, with the industry benchmark Horizons Marijuana Life Sciences Index ETF trading over 25% down for this year.

However, recreational cannabis sales have been rising after a marginal pullback in April amid the temporary closure of retail stores. In July, Canada’s recreational cannabis sales stood at $2316 million, representing a 15.2% rise from its June sales. With provincial governments addressing the issue of the slow rollout of retail stores, all provinces have reported a surge in their sales.

Given the cannabis sales growth, should you buy Aurora Cannabis (TSX:ACB)(NYSE:ACB) and HEXO (TSX:HEXO)(NYSE:HEXO), which are trading at deeper discounts?

The case for Aurora Cannabis

Aurora Cannabis has been on a downward momentum, losing over 81% of its stock value this year and 96% from its all-time high. The company is yet to become profitable. It has raised capital several times through new equity offerings in the last few years. Further, it wrote down millions of dollars’ worth of inventory amid weaker demand and has reported $1.8 billion in goodwill impairment charges, which have weighed on its stock price.

The company’s revenue declined 5% on a sequential basis to $72.1 million in its recently completed fourth quarter. The decline in the consumer cannabis segment’s revenue due to the unfavourable mix and fall in its vaporizer products’ market share dragged its sales down. However, its medical segment’s revenue grew 4%, driven by strong performance in the Canadian and European markets.

Its adjusted EBITDA losses improved from $50.4 million to $34.6 million. The improvement in gross margin and lower SG&A (selling, general, and administrative) expenses led to an improvement in its adjusted EBITDA. Meanwhile, the company’s management expects to achieve positive EBITDA by the second quarter of fiscal 2021.

So, Aurora Cannabis is working on lowering its production cost and also SG&A expenses to achieve its target. Meanwhile, analysts are skeptical about the company’s optimistic target. BMO Capital Markets expects the company to take three years to attain sustainable profitability.

The case for HEXO

This year, HEXO has lost over 50% of its stock value while trading around 90% lower from its all-time high. The company’s high cash burn and dilution amid capital raising through new equity offerings have dragged its stock down.

Meanwhile, its top line grew around 30% on a sequential basis to $30.9 million in its third quarter, which ended on April 30. The strong performance from its value brand, Original Stash, and its new product offering drove its sales. Its adjusted EBITDA losses also improved from $8.5 million to $4.3 million. Meanwhile, the company sold its Niagara facility to align its production with the lower-than-expected demand.

In July, HEXO expanded its vape products to all the provinces in Canada. During the same month, it launched its medical products in Israel. Further, in association with beer maker Molson Coors, it has launched five THC- and CBD-infused beverages in Canada. So, its growth prospects look healthy.

Bottom line

Although both companies are available at a deeper discount, I believe investing in both these companies is risker, given their high cash burn and lower liquidity position. Meanwhile, investors looking for cannabis exposure could invest in Canopy Growth or Aphria, which have a strong balance sheet and a viable business model.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »